Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • David [R]
    Member
    • Jul 2012
    • 12

    #1

    edgeR, "DGELIst" function, "group" parameter

    Hi,

    I am using edgeR for some RNASeq analysis. My question concerns the DGEList function and its "group" parameter. I realized that, whether doing group=mydesignfactor or group=rep(1,ncol(counts)), the cpm numbers that I get after
    counts.TMM <- calcNormFactors(counts.DGEList)
    cpm.TMM=cpm(counts.TMM, normalized.lib.sizes=TRUE)
    are strictly identical in either case. The only difference between both ways is that the counts.TMM$samples$group column duly reflects what I put in in "group".

    Is this normal? What is it that I am missing? Is the "group" nevertheless taken into account on the subsequent estimateGLMCommonDisp, estimateGLMTrendDisp, estimateGLMTagDisp, glmFit, glmLRT etc.?

    Thanks in advance for your help.

    Best,

    David Rengel
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    There's no reason that cpm should be dependent upon your experimental design (in fact, it shouldn't be). The various GLM function pay attention to the design, since that's where it's important.

    Comment

    • David [R]
      Member
      • Jul 2012
      • 12

      #3
      Hi dpryan,

      THanks for your reply. Yes, that is right. My only only doubt came from de fact that if normalized.lib.sizes=TRUE, then the cpm are calculated using the normalization factors, which I thought were somehow dependent on your experimental design, but it seems I was mistaken.

      David

      Comment

      • dpryan
        Devon Ryan
        • Jul 2011
        • 3478

        #4
        Correct, normalization factors are independent from experimental design.

        Comment

        • David [R]
          Member
          • Jul 2012
          • 12

          #5
          Thanks a lot!

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
            by SEQadmin2



            CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

            Despite this, “CRISPR helped turn genome editing from a specialized technique into
            ...
            07-31-2026, 11:01 AM
          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, Today, 07:41 AM
          0 responses
          9 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 08-03-2026, 10:13 AM
          0 responses
          25 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-31-2026, 02:55 AM
          0 responses
          38 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          25 views
          0 reactions
          Last Post SEQadmin2  
          Working...